Core Viewpoint - DuPont de Nemours, Inc. is amending its exchange offers for existing notes to facilitate the issuance of new notes, while also soliciting consents for proposed amendments to the existing indenture governing these notes [1][2]. Exchange Offers - DuPont is offering to exchange its outstanding 4.725% Notes due 2028, 5.319% Notes due 2038, and 5.419% Notes due 2048 for new notes with the same interest rates and maturities [1]. - The exchange offers are set to expire on September 30, 2025, unless extended or terminated [9]. Consent Solicitation - As of September 15, 2025, the necessary consents for the proposed amendments regarding the 2028 Notes have been received, leading to the execution of a supplemental indenture [2]. - The proposed amendments for the 2028 Notes will only become operative once the new notes are issued and the applicable early participation payment is made [2]. Consideration Structure - Eligible holders of existing notes can receive an early participation payment of $50 in new notes and $2.50 in cash for each $1,000 principal amount of existing notes tendered before the early participation date [3]. - The total consideration for each $1,000 principal amount of existing notes validly tendered includes $950 in new notes plus the early participation payment [3][4]. Proration and Sublimits - If the requisite consents for the 2038 and 2048 Notes are not received, DuPont plans to waive the minimum tender condition and accept existing notes up to specified sublimits: $400 million for the 2038 Notes and $860 million for the 2048 Notes [6]. - In cases where the tendered amount exceeds the sublimits, a pro rata basis will be used to determine the amount accepted for exchange [6][7]. Redemption Plans - If the principal amount of either the 2038 or 2048 Notes tendered is less than the applicable sublimit, DuPont intends to redeem additional amounts of new or outstanding 2028 Notes [8]. Additional Information - Documents related to the exchange offers will be distributed only to eligible holders who meet specific criteria [9]. - The new notes have not been registered under the Securities Act and may not be offered or sold in the U.S. except under certain exemptions [10].